Arcus Ventures is a private equity general partner firm headquartered in New York, NY, United States.
Biopharmaceutical company Cleave Biosciences completed a $37m Series B financing round from Arcus Ventures, NEA, 5AM Ventures and others.
Exosome Diagnostics, a liquid biopsy platform that enables non-invasive diagnosis of serious diseases, raised $60m in Series B financing.
Exosome Diagnostics, a developer of biofluid-based molecular diagnostics, completed a $17.6m Series B round from NGN Capital and others.
Read more news concerning Arcus Ventures
A sampling of Arcus Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?